ScienceDaily
July 16, 20261 min read
Researchers solved a long-standing mystery behind how a bacterial toxin associated with colorectal cancer damages the colon. The toxin first binds to a receptor called claudin-4, giving it access to attack the cells' protective barrier. After identifying this weak point, the team designed a decoy protein that successfully blocked the toxin in mice. The discovery could pave the way for new therapies to prevent inflammation and colon tumors.
Read what's here, then head to the original whenever you're ready - never required.
Continue Reading on ScienceDaily
Advancing next-gen AI with materials science innovation
Hacker News July 21, 2026